TGFB1 and cancer: miR-155 is a well-documented oncomiRNA in hematology, known for promoting cancer progression by upregulating key factors such as Cyclin D1, Cyclin E2, CDK4, CDK6, SOCS6-STAT3, NF-κB, and TGF-β 34, 55-57.